BCL2 and diffuse large B-cell lymphoma: The overlapping morphological and genetic characteristics among entities in the heterogeneous group of LBCL necessitate the clinical distinction of HGBCL, not otherwise specified (NOS) from the DLBCL/HGBCL group with MYC and BCL2 rearrangements.